Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/MRK stock hub

ETR/MRK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/MRKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

49.1B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/MRK

In the news

Latest news · ETR/MRK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 12.3P50 15.7P75 20.2

Trailing P/E18.8

P25 16.4P50 20.9P75 30.4

ROE8.9

P25 -6.7P50 8.5P75 17.2

ROIC8.2

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/MRK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

EUR

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	59,077
Employees Change	57%
Employees Change Percent	0.1
Enterprise value	EUR 57.8B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	DE0006599905
Last refreshed	2026-05-10
Market cap	EUR 49.1B
Price	EUR 113
Price currency	EUR
Rev Per Employee	357,194.85x
Sector	Healthcare
Sic	2834
Symbol	etr/MRK
Website	https://www.emdgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.32%
EV Earnings	22.15x
EV/EBIT	14.7x
EV/EBITDA	10.13x
EV/FCF	24.61x
EV/Sales	2.74x
FCF yield	4.78%
Forward P/E	14.55x
P/B ratio	1.71x
P/E ratio	18.81x
P/S ratio	2.33x
PE Ratio10 Y	23.04x
PE Ratio3 Y	21.86x
PE Ratio5 Y	23.5x
PEG ratio	1.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.62%
EBITDA Margin	27.01%
FCF margin	11.12%
Gross margin	58.9%
Gross Profit	EUR 12.4B
Gross Profit Growth	-0.77%
Gross Profit Growth Q	-3.06%
Gross Profit Growth3 Y	-3.27%
Gross Profit Growth5 Y	2.94%
Net Income	EUR 2.6B
Net Income Growth	-6.09%
Net Income Growth Q	-52.17%
Net Income Growth Years	0%
Net Income Growth3 Y	-7.79%
Net Income Growth5 Y	5.59%
Pretax Margin	15.68%
Profit Margin	12.36%
Profit Per Employee	EUR 44,146
Profitable Years	24
ROA	4.76
Roa5y	5.55
ROCE	9.25
ROE	8.92
Roe5y	11.9
ROIC	8.23
Roic5y	10.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.07%
Cagr15y	9.13%
Cagr1y	-4.95%
Cagr20y	6.82%
Cagr3y	-10.42%
Cagr5y	-3.11%
Div CAGR10	7.68%
Div CAGR3	0%
Div CAGR5	9.46%
EPS Growth	-6.09
EPS Growth Q	-52.17
EPS Growth Years	0
EPS Growth3 Y	-7.79
EPS Growth5 Y	5.59
FCF Growth	-18.62%
FCF Growth Q	5.83%
FCF Growth3 Y	-4.89%
FCF Growth5 Y	2.6%
OCF Growth	-14.26%
OCF Growth Q	4.87%
OCF Growth10 Y	6%
OCF Growth3 Y	-2.63%
OCF Growth5 Y	2.49%
Revenue Growth	-0.26x
Revenue Growth Q	-3.12x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.72x
Revenue Growth5 Y	3.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 51.5B
Cash	EUR 3.3B
Current Assets	EUR 13.2B
Current Liabilities	EUR 9B
Debt	EUR 12B
Debt EBITDA	EUR 2.1
Debt Equity	EUR 0.42
Debt FCF	EUR 5.1
Equity	EUR 28.7B
Interest Coverage	12.06
Liabilities	EUR 22.9B
Long Term Assets	EUR 38.3B
Long Term Liabilities	EUR 13.8B
Net Cash	EUR -8.6B
Net Cash By Market Cap	EUR -17.59
Net Debt EBITDA	EUR 1.51
Net Debt Equity	EUR 0.3
Net Debt FCF	EUR 3.68
Tangible Book Value	EUR 3B
Tangible Book Value Per Share	EUR 6.9
WACC	7.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.46
Inventory Turnover	1.92
Net Working Capital	EUR 2.1B
Quick ratio	0.9
Working Capital	EUR 4.2B
Working Capital Turnover	EUR 6.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 2.2
Dividend Years	31
Dividend Yield	1.95%
Ex Div Date	2026-04-27
Last Dividend	EUR 2.2
Payout Frequency	Annual
Payout Ratio	39.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	64.02%
1Y total return	-4.94%
200-day SMA	115.4
3Y total return	-28.12%
50-day SMA	112.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-14.62%
All Time High	231.5
All Time High Change	-51.25%
All Time High Date	2021-12-30
All Time Low	8.9
All Time Low Change	1,167.98%
All Time Low Date	2002-10-01
ATR	3.19
Beta	0.78
Beta1y	1.61
Beta2y	1.08
Ch YTD	-7.95
High	114
High52	131.7
High52 Date	2026-01-12
High52ch	-14.28%
Low	112.2
Low52	100.7
Low52 Date	2026-03-23
Low52ch	12.07%
Ma50ch	0.44%
Price vs 200-day SMA	-2.23%
RSI	50.86
RSI Monthly	40.79
RSI Weekly	46.63
Sharpe ratio	-0.24x
Sortino ratio	-0.14
Total Return	1.95%
Tr YTD	-6.11
Tr15y	270.89%
Tr1m	7.23%
Tr1w	3.15%
Tr3m	-5.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.9B
Operating Income Growth	-6.65
Operating Income Growth Q	-33.38
Operating Income Growth3 Y	-7.58
Operating Income Growth5 Y	5.06
Operating margin	18.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	129,236,151%
Net Borrowing	1,677,000,000
Shares Institutions	15.1%
Shares Out	434,777,878
Shares Qo Q	-0.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.3B
Average Volume	347,269.95x
Bv Per Share	65.76
CAPEX	EUR -1.6B
Ch10y	42.78
Ch15y	200.9
Ch1m	5.12
Ch1w	3.15
Ch1y	-6.81
Ch20y	164.4
Ch3m	-7.08
Ch3y	-31.81
Ch5y	-20.95
Ch6m	3.11
Change	-1.66%
Change From Open	-0.75
Close	114.8
Days Gap	-0.92
Depreciation Amortization	1,770,000,000
Dollar Volume	27,172,474.4
Earnings Date	2026-05-13
EBIT	EUR 3.9B
EBITDA	EUR 5.7B
EPS	EUR 6
F Score	5
FCF	EUR 2.3B
FCF EV Yield	4.06x
FCF Per Share	EUR 5.4
Financing CF	628,000,000
Fiscal Year End	December
Founded	1,668
Goodwill	17,934,000,000
Graham Number	94.32259
Graham Upside	-16.42
Income Tax	EUR 693M
Investing CF	-4,261,000,000
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Date	2014-06-30
Last Split Type	Forward
Lynch Fair Value	EUR 33.53
Lynch Upside	-70.29
Ma150	117.5
Ma150ch	-3.95%
Ma20	113.3
Ma20ch	-0.44%
Net CF	223,000,000
Next Earnings Date	2026-05-13
Open	113.7
P FCF Ratio	20.91
P OCF Ratio	12.48
Payment Date	2026-04-29
Position In Range	37.84
Ppne	9,940,000,000
Price Date	2026-05-08
Price EBITDA	EUR 8.61
Ptbv Ratio	16.37
Relative Volume	0.72x
Revenue	21,102,000,000x
Tax By Revenue	3.28x
Tax Rate	20.95%
Tr20y	274%
Tr6m	5.17%
Volume	240,784
Z Score	2.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/MRK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$2.20 annual per share

Payout ratio

+39.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.5%

0 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-04-27

Performance

ETR/MRK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/MRK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/MRK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.9

Neutral momentum band

Price vs 200-day MA

-2.2%

50/200-day relationship not available

Beta (5Y)

0.78

Less volatile than the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/MRK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/MRK stock rating?

etr/MRK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/MRK analysis?

The full report lives at /stocks/etr/MRK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/MRK?

The latest report frames etr/MRK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/MRK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.